The DOI matches its Crossref record; 282 of the 282 references it cites were found in a registry or an index.
Immune and inflammatory mechanisms in hypertension
Open accessAbstract
Hypertension is a global health problem, with >1.3 billion individuals with high blood pressure worldwide. In this Review, we present an inflammatory paradigm for hypertension, emphasizing the crucial roles of immune cells, cytokines and chemokines in disease initiation and progression. T cells, monocytes, macrophages, dendritic cells, B cells and natural killer cells are all implicated in hypertension. Neoantigens, the NLRP3 inflammasome and increased sympathetic outflow, as well as cytokines (including IL-6, IL-7, IL-15, IL-18 and IL-21) and a high-salt environment, can contribute to immune activation in hypertension. The activated immune cells migrate to target organs such as arteries (especially the perivascular fat and adventitia), kidneys, the heart and the brain, where they release effector cytokines that elevate blood pressure and cause vascular remodelling, renal damage, cardiac hypertrophy, cognitive impairment and dementia. IL-17 secreted by CD4+ T helper 17 cells and γδ T cells, and interferon-γ and tumour necrosis factor secreted by immunosenescent CD8+ T cells, exert crucial effector roles in hypertension, whereas IL-10 and regulatory T cells are protective. Effector mediators impair nitric oxide bioavailability, leading to endothelial dysfunction and increased vascular contractility. Inflammatory effector mediators also alter renal sodium and water balance and promote renal fibrosis. These mechanisms link hypertension with obesity, autoimmunity, periodontitis and COVID-19. A comprehensive understanding of the immune and inflammatory mechanisms of hypertension is crucial for safely and effectively translating the findings to clinical practice. In this Review, Guzik and colleagues discuss immune and inflammatory mechanisms of hypertension, including upstream regulators and downstream effectors as well as the complex interplay between the immune system, blood pressure regulation and end-organ damage, which can help to identify new targets for therapeutic interventions. Hypertension is a global health challenge, affecting >1.3 billion people worldwide, and the development of this condition is closely associated with inflammatory dysregulation and immune activation. Immune cells such as CD8+ T cells, T helper 17 cells, regulatory T cells, monocytes, macrophages and B cells, as well as chemokines and cytokines, such as IL-17, IL-18, interferon-γ and tumour necrosis factor, have crucial roles in the immune mechanisms underlying hypertension. Relevant immune mechanisms can be grouped into two clusters: those involved in the regulation of the initial immune and inflammatory activation, and the immune effector mechanisms linking the immune system to end-organ mechanisms that regulate blood pressure. Dendritic cells presenting neoantigens, NLRP3 inflammasome activity and neuroimmune activation all contribute to the immune activation process in hypertension. Activated immune cells migrate to target organs, such as the arteries (especially the perivascular fat and adventitia), kidneys and brain, causing end-organ damage and elevating the blood pressure. A deeper understanding of the immune crosstalk between the upstream regulators and downstream effectors in hypertension will enable the application of these findings effectively in clinical settings. Hypertension is a global health challenge, affecting >1.3 billion people worldwide, and the development of this condition is closely associated with inflammatory dysregulation and immune activation. Immune cells such as CD8+ T cells, T helper 17 cells, regulatory T cells, monocytes, macrophages and B cells, as well as chemokines and cytokines, such as IL-17, IL-18, interferon-γ and tumour necrosis factor, have crucial roles in the immune mechanisms underlying hypertension. Relevant immune mechanisms can be grouped into two clusters: those involved in the regulation of the initial immune and inflammatory activation, and the immune effector mechanisms linking the immune system to end-organ mechanisms that regulate blood pressure. Dendritic cells presenting neoantigens, NLRP3 inflammasome activity and neuroimmune activation all contribute to the immune activation process in hypertension. Activated immune cells migrate to target organs, such as the arteries (especially the perivascular fat and adventitia), kidneys and brain, causing end-organ damage and elevating the blood pressure. A deeper understanding of the immune crosstalk between the upstream regulators and downstream effectors in hypertension will enable the application of these findings effectively in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circos: An information aesthetic for comparative genomics
Krzywinski, M., Schein, J., Birol, İ., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 10,964
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., Gregg, E. W., Bennett, J. E., Solomon, B., Singleton, R. K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01330-1 · Cited by 3,902
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
The International Consortium for Blood Pressure Genome-Wide Association Studies (2011) · Nature · doi:10.1038/nature10405 · Cited by 2,033
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Self-citationZhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00559-8 · Cited by 1,521
Gut Dysbiosis Is Linked to Hypertension
Yang, T., Santisteban, M. M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J. M., Zadeh, M., Gong, M., Qi, Y., Zubcevic, J., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05315 · Cited by 1,478
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells
Kleinewietfeld, M., Manzel, A., Titze, J., Kvakan, H., Yosef, N., Linker, R. A., Muller, D. N., & Hafler, D. A. (2013) · Nature · doi:10.1038/nature11868 · Cited by 1,394
Cited by
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Guzik, T. J., Nosalski, R., Maffia, P., & Drummond, G. R.
- Venue
- Nature Reviews Cardiology
- Published
- 2024-01-03
- Volume
- 21
- Issue
- 6
- Pages
- 396-416
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W4390571844
- Cited by
- 315
- References
- 282
- FWCI
- 16.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immune and inflammatory mechanisms in hypertension. https://app.cochat.ai/papers/10.1038/s41569-023-00964-1
- The paper
- Guzik, T. J., Nosalski, R., Maffia, P., & Drummond, G. R. (2024). Immune and inflammatory mechanisms in hypertension. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-023-00964-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.